Rury R. Holman

Endocrinology, Diabetes and Metabolism · 2000–2021

A researcher in the Science corpus: 26 papers; trusts 1 researcher and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

• Endocrinology, Diabetes and Metabolism — 216 citations into it; #106 of 623 by trust here, #5 by citations
• Molecular Biology — 61 citations into it; #14,898 of 17,773 by trust here, #2,408 by citations

Whom Rury R. Holman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. D. Nathan

Who trusts Rury R. Holman overall

1. V. Basevi
2. Ralph DeFronzo
3. K. Bornfeldt
4. A. Chawla
5. Joshua A. Beckman
6. Silvio E. Inzucchi
7. F. Paneni
8. John B. Buse
9. S. Grundy
10. I. Tabas

Papers from Rury R. Holman's perspective

Ordered by how strongly the researchers Rury R. Holman trusts endorse each paper. Same corpus, a different order for every researcher.

1. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study (British medical journal)
2. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. (Cochrane Database of Systematic Reviews)
3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
4. Glucose control and vascular complications in veterans with type 2 diabetes. (New England Journal of Medicine)
5. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). (Clinical science)
6. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) (British medical journal)
7. Long-term follow-up after tight control of blood pressure in type 2 diabetes. (New England Journal of Medicine)
8. Relationship between obesity, insulin resistance, and coronary heart disease risk. (Journal of the American College of Cardiology)
9. Correcting for regression dilution bias: comparison of methods for a single predictor variable
10. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (Diabetes Care)

Their papers

• 10-year follow-up of intensive glucose control in type 2 diabetes. (2008) — 6,946 citations
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2006) — 954 citations
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) — 2,670 citations
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. (2006) — 1,710 citations
• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) — 619 citations
• The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. (2020) — 616 citations
• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. (2018) — 1,439 citations
• Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes (2017) — 1,746 citations
• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. (2015) — 2,285 citations
• Effect of valsartan on the incidence of diabetes and cardiovascular events. (2010) — 648 citations
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes (2009) — 2,915 citations
• Intensive glucose control and macrovascular outcomes in type 2 diabetes (2009) — 1,096 citations
• Three-year efficacy of complex insulin regimens in type 2 diabetes. (2009) — 648 citations
• Long-term follow-up after tight control of blood pressure in type 2 diabetes. (2008) — 746 citations
• Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy (2008) — 751 citations
• Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. (2007) — 692 citations
• Effect of ramipril on the incidence of diabetes. (2006) — 649 citations
• Risk Factors for Renal Dysfunction in Type 2 Diabetes (2006) — 717 citations
• A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004) — 610 citations
• Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition (2004) — 6,333 citations